Navigation Links
Hebrew University scientist develop technique for eliminating reblockage of arteries
Date:3/9/2009

Jerusalem, March 9, 2009 An easily implementable technique to avoid reblockage of arteries that have been cleared through angioplasty and stent insertion has been developed by researchers led by Prof. Boris Rubinsky of the Hebrew University of Jerusalem.

Angioplasty is the "gold-standard" treatment for acute myocardial infarction (heart attack), which is the result of abrupt interruption in blood supply to part of the beating heart, usually due to plaque-rupture in an atherosclerotic (hardened) coronary artery.

In angioplasty, a cardiologist dilates the blocked artery by inserting a balloon that is inflated at the point of blockage. This is usually followed by coronary stent implantation to protect the artery and prevent restenosis (reocclusion or reblockage). However, the procedure damages the arterial wall, and therefore restonosis of the dilated artery remains a major clinical problem in cardiology, as well as in other fields of clinical medicine.

Since heart disease remains the leading cause of mortality in the western world, the technique developed by Prof. Rubinsky's research teams offer a highly valuable tool for dealing with cardiology patients. Prof. Rubinsky is the director of the Center for Bioengineering in the Service of Humanity and Society at the Rachel and Selim Benin School of Computer Science and Engineering of the Hebrew University of Jerusalem and a professor in the graduate school at the University of California, Berkeley.

The technique employs the biophysical phenomenon of irreversible electroporation (IRE). IRE destroys cells within seconds, using very short electric field pulses. It causes no damage to structures other than the cells themselves. Compared with other technologies for local destruction of cells and tissue, IRE is simple and does not require special training of the medical team.

In IRE, electrical fields are applied across targeted cells, penetrating the cell membranes, Thi
'/>"/>

Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-258-82904
The Hebrew University of Jerusalem
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Hebrew University scientists succeed through stem cell therapy in reversing brain birth defects
2. Event Honoring Bill Gates Raises Over $1.5 Million for Sustainable Agriculture Research at The Hebrew University of Jerusalem
3. The Connecticut Hospice, Inc. Announces the Arrival of Six Nurse Scholars From The Henrietta Szold-Hadassah-Hebrew University School of Nursing
4. RNA engineering to combat series of illnesses wins Kaye Award for Hebrew University dean
5. Hebrew University research on octopuses sheds light on memory
6. Humans have more distinctive hearing than animals, Hebrew U study shows
7. Robert H. Smith Feeding the Future with $15 Million Gift to Hebrew University of Jerusalem
8. Hebrew SeniorLife researcher finds
9. 2 Hebrew University scientists awarded Wolf Prizes
10. NorthShore University HealthSystem Only Hospital in the Region to Use Incisionless Procedure to Reduce Weight Regain
11. New Tel Aviv University research links diabetes to cognitive deterioration

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ay seem like unlikely heroes in the battle against...insects already used to study dozens of human dis...ing that fruit flies can be used as a simpler and ...cts of cocaine and other drugs of abuse on the bra...uroscience , a new monthly journal. , Andrew Ew...
(Date:12/2/2009)... ILS Technology and ASML Receive Innovatio...ca Raton, Fla. (PRWEB) December 2, 2009 -- ILS Tec...ligence through connectivity, today announced that...h recognized with awards for technical innovation ...o, the International Society of Automation (ISA) n...
(Date:12/2/2009)...AN DIEGO, Dec. 2 US Farm...r of Farming, Nursery and Wellness products, is pl...5(TM) products at the Cook,sware A,faire in Oaklan...009. ,, For additional information, contact US ...FARMS or visit http://cookswareafaire.com ,, ...
(Date:12/2/2009)...ILLE, Tenn., Dec. 2 Aegis Health G...elopment company, has appointed Pearson Talbert as...executive management team, Talbert will provide le...ff as they focus on solutions to help hospitals gr...ician relationships. ,, To this newly created p...
(Date:12/2/2009)...sts the gene could be linked to life span in males...-- Sperm genes may affect life span in humans and ...end to live longer than males, Japanese scientists... using two female genomes -- bi-maternal mice -- l...ed from the normal combination of a male and femal...
Breaking Medicine News(10 mins):Health News:ILS Technology and Customer ASML Recipients of Industry Recognition Awards 2Health News:US Farms, Inc. Showcasing Aloe365(TM) Product Line at Cook'sware A'faire at Oakland Zoo 2Health News:Aegis Health Group Hires Pearson Talbert as Chief Development Officer 2Health News:Sperm Gene May Cause Men's Longevity Disadvantage 2
...ril 18 ,HeartWare Limited (ASX: HTW) today announc...facturing facility in Miami Lakes, FL, USA. The ne...ice the size of HeartWare,s,current facility, will...y leased by Cordis Neurovascular, Inc., a,division...
...ciences Discovery Fund (LSDF) has today awarded $2...ased life sciences organizations and their partner...cus on the areas of medical genetics, autoimmunity...re: Gail Jarvik, University of Washington; Gerald ...
...e, Inc. today,announced that the Woodland Park Car...rst skilled nursing facility in the state of Utah ...) from the American Association,for Respiratory Ca...iding a,higher level of medical care within our sk...
...taining the veterinary blood supply , , FR...erica,s blood donors, JJ and Logan are unaware of ...d. , But over a three-year period, the two healthy...e dogs, owner, Joanna Goriss of Deerfield Beach, F...
...e,Robert Weiner, and Dr. Patricia Berg, director o...rting that many scientists believe that "the,cost ...in real dollars for,cancer research, and private o....", Weiner and Berg just returned from the annual...
...ote goes,hungry in cartoon land, it,s because Road...unner Food Bank wins when nobody goes hungry., (P...7/LATH545-a ), (Photo: http://www.newscom.com/cg...t the tragedy of hunger in New,Mexico and what peo...
Other Medicine News:Health News:HeartWare Announces Move to an Expanded, Upgraded Manufacturing Facility 2Health News:HeartWare Announces Move to an Expanded, Upgraded Manufacturing Facility 3Health News:Life Sciences Fund grants awards to launch health research 2Health News:Life Sciences Fund grants awards to launch health research 3Health News:Life Sciences Fund grants awards to launch health research 4Health News:Life Sciences Fund grants awards to launch health research 5Health News:Woodland Park Care Center Earns Quality Respiratory Care Recognition 2Health News:Donor Dogs Give the Gift of Life 2Health News:Donor Dogs Give the Gift of Life 3Health News:Donor Dogs Give the Gift of Life 4Health News:Reduced Funds for Cancer is Cost of Iraq, Say Ex-White House Aide, Cancer Researchers 2Health News:BEEP BEEP!! Strategic Communications Firm DW Turner Thwarts Hunger in Partnership With Roadrunner Food Bank 2
(Date:12/2/2009)... , , NANJING, China, Dec. 2 /PRNe...cere" or the "Company") (NYSE: SCR ), a leading ...ment, manufacturing, and marketing of branded,gene...y reported that its,subsidiary Jiangsu Yanshen Bio...en") has suspended production of all its products ...
(Date:12/1/2009)... , , TEMECULA, Calif., Dec. 1 /PRNewswire...OTC Bulletin Board: PSTX) announced today that it ...on of Chief Financial Officer, Treasurer and Corpo...n acting CFO since 2008. Prior to joining Patient...ident Finance, Chief Financial Officer, Treasurer ...
(Date:12/1/2009)... , , NEW YORK, Dec. 1 /PRNewswire/...esearch report is available in its catalogue: ,... Review ,, http://www.reportlinker.com/p01643...ew.html ,, Over the years, Liquid Chromatograp...ciences, pharmaceuticals, food and beverage, resea...
Breaking Medicine Technology:Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3Patient Safety Technologies, Inc. Appoints Marc L. Rose, CPA (PA), Chief Financial Officer 2Reportlinker Adds HPLC Systems & Accessories - A World Market Review 2Reportlinker Adds HPLC Systems & Accessories - A World Market Review 3Reportlinker Adds HPLC Systems & Accessories - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 5Reportlinker Adds HPLC Systems & Accessories - A World Market Review 6Reportlinker Adds HPLC Systems & Accessories - A World Market Review 7VBI awarded 2427 million from NIH to support infectious disease research 10266 1VBI awarded 2427 million from NIH to support infectious disease research 10266 2VBI awarded 2427 million from NIH to support infectious disease research 10266 3VBI awarded 2427 million from NIH to support infectious disease research 10266 4Aurora Health Care Among Six Sites Chosen for National Medicare Collaborative on Geriatric Care 58886 1Aurora Health Care Among Six Sites Chosen for National Medicare Collaborative on Geriatric Care 58886 2Aurora Health Care Among Six Sites Chosen for National Medicare Collaborative on Geriatric Care 58886 3Aurora Health Care Among Six Sites Chosen for National Medicare Collaborative on Geriatric Care 58886 4Hanger Orthopedic Group Inc Announces Third Quarter 2009 Earnings Release Conference Call 58881 1Hanger Orthopedic Group Inc Announces Third Quarter 2009 Earnings Release Conference Call 58881 2
...AN, Utah, Oct. 19 Facet Solutions, Inc. announced...thopedic surgeon at,Century City Doctors Hospital ...D., associate professor and neurosurgeon at Albany...ompleted additional surgical,procedures utilizing ...FRS(TM)) as part of an FDA approved IDE Clinical T...
...AXIMA findings in The Lancet affirm the maintenanc...ess frequent dosing -, NUTLEY, N.J., Oct. 19 A p...wn that dialysis patients were effectively switche...ive investigational anemia,treatment, MIRCERA(R), ...AXIMA study is the first randomized, comparative s...
Other Medicine Technology:Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM)) 2Pivotal MIRCERA(R) Study First to Convert Dialysis Patients From Frequent Dosing Directly to Once Every Two Weeks or Once Every Four Weeks 2Pivotal MIRCERA(R) Study First to Convert Dialysis Patients From Frequent Dosing Directly to Once Every Two Weeks or Once Every Four Weeks 3Pivotal MIRCERA(R) Study First to Convert Dialysis Patients From Frequent Dosing Directly to Once Every Two Weeks or Once Every Four Weeks 4
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
Medicine Products: